This is a single ascending dose trial in healthy volunteers. The study will be conducted in
up to 7 cohorts. Upon review of the safety and PK data, it may be decided to expand the
current cohort versus dose escalate to the next cohort. In addition, the sponsor may elect
not to enroll all 7 cohorts based on safety and/or PK and/or PD data.